Rebecca C. Fitzgerald
Pre-Invasive Disease: Pathogenesis and Clinical Management
Paperback Engels 2014 9781489982254
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
This book is written by International experts in their field and should appeal to students and seasoned researchers, to scientists and to clinicians. No prior knowledge of the topic is required to appreciate this text and yet the book charters new territory. New perspectives are given on how our knowledge of cancer development might lead us to reconsider our clinical approach to early detection and prevention of cancer at an individual and population level.
Specificaties
ISBN13:9781489982254
Taal:Engels
Bindwijze:paperback
Uitgever:Springer New York
Lezersrecensies
Wees de eerste die een lezersrecensie schrijft!
Inhoudsopgave
<P>Guest editorial: Professor Sir Bruce Ponder (AGREED) </P>
<P>1. Epidemiology: public health burden, increasing disease and/or increasing detection, lag phase, risk factors ? Prof. John Potter Fred Hutchinson Centre/? Paul Pharoah</P>
<P>2. Pathogenesis:</P>
<P>- cancer stem cells: Prof. Sir Nick Wright, London Research Institute</P>
<P>- inflammation: Lisa Coussens, University California San Francisco</P>
<P>- hereditary factors: Paul Pharoah/Bruce Ponder CRI, Cambridge</P>
<P>- acquired mutations: Doug Hanahan /Robert Weinberg, University California San Francisco</P>
<P>- Epigenetics: E.G. William Nelson Baltimore/ Steve Meltzer John Hopkins USA</P>
<P>3. Animal models and other model systems of pre-invasive disease e.g. Tyler Jacks MIT or Dave Tuveson, CRI cambridge</P>
<P>4. Biomarkers – tissue, serum, fluids: Prof. Brian Reid, Fred Hutchinson Cancer Center, Seattle or Barbara Weber, GSK Pharmaceuticals</P>
<P>5. Molecular imaging: Professor Kevin Brindle Cambridge Research Institute, UK or Gary Kelloff NCI, Rockville</P>
<P>6. Issues around screening/surveillance: psychosocial, economic: Dr. Dawn Provenzale Duke University/ Karen Basen-Engquist MD Anderson texas/ prof Jane Blazeby Bristol UK</P>
<P>7. Disease specific examples:</P>
<P>Lung: Herman Baltimore</P>
<P>Mouth: Miriam Rosin Vancouver</P>
<P>Oesophagus: Dr Rebecca Fitzgerald, Cambridge UK</P>
<P>Stomach: Dr. Tim Wang, Columbia Univ, New York</P>
<P>Colon: Prof Bert Vogelstein, John Hopkins USA, John Potter, Seattle</P>
<P>Breast: Prof Stephen Duffty, CRUK, UK</P>
<P>Cervix –papsmear/vaccines: TC Wu, Johns Hokins Baltimore</P>
<P>Prostate/bladder: Professor David Neal, CRI Cambridge</P>
<P>8. Chemoprevention: e.g. Prof. John Potter Fred Hutchinson Centre </P>
<P>9. Treatment of early lesions: Jacques Van Dam Stanford / or Jacques Bergman Amsterdam</P>
<P>10. Common threads: areas for future research and future costs.benefits to society for early detection: or Michael Sporn Dartmouth Med Sch New Hampshire, or Gary Kelloff NCI, Maryland or Prof. George Triadafilopoulos, Stanford</P>
<P>1. Epidemiology: public health burden, increasing disease and/or increasing detection, lag phase, risk factors ? Prof. John Potter Fred Hutchinson Centre/? Paul Pharoah</P>
<P>2. Pathogenesis:</P>
<P>- cancer stem cells: Prof. Sir Nick Wright, London Research Institute</P>
<P>- inflammation: Lisa Coussens, University California San Francisco</P>
<P>- hereditary factors: Paul Pharoah/Bruce Ponder CRI, Cambridge</P>
<P>- acquired mutations: Doug Hanahan /Robert Weinberg, University California San Francisco</P>
<P>- Epigenetics: E.G. William Nelson Baltimore/ Steve Meltzer John Hopkins USA</P>
<P>3. Animal models and other model systems of pre-invasive disease e.g. Tyler Jacks MIT or Dave Tuveson, CRI cambridge</P>
<P>4. Biomarkers – tissue, serum, fluids: Prof. Brian Reid, Fred Hutchinson Cancer Center, Seattle or Barbara Weber, GSK Pharmaceuticals</P>
<P>5. Molecular imaging: Professor Kevin Brindle Cambridge Research Institute, UK or Gary Kelloff NCI, Rockville</P>
<P>6. Issues around screening/surveillance: psychosocial, economic: Dr. Dawn Provenzale Duke University/ Karen Basen-Engquist MD Anderson texas/ prof Jane Blazeby Bristol UK</P>
<P>7. Disease specific examples:</P>
<P>Lung: Herman Baltimore</P>
<P>Mouth: Miriam Rosin Vancouver</P>
<P>Oesophagus: Dr Rebecca Fitzgerald, Cambridge UK</P>
<P>Stomach: Dr. Tim Wang, Columbia Univ, New York</P>
<P>Colon: Prof Bert Vogelstein, John Hopkins USA, John Potter, Seattle</P>
<P>Breast: Prof Stephen Duffty, CRUK, UK</P>
<P>Cervix –papsmear/vaccines: TC Wu, Johns Hokins Baltimore</P>
<P>Prostate/bladder: Professor David Neal, CRI Cambridge</P>
<P>8. Chemoprevention: e.g. Prof. John Potter Fred Hutchinson Centre </P>
<P>9. Treatment of early lesions: Jacques Van Dam Stanford / or Jacques Bergman Amsterdam</P>
<P>10. Common threads: areas for future research and future costs.benefits to society for early detection: or Michael Sporn Dartmouth Med Sch New Hampshire, or Gary Kelloff NCI, Maryland or Prof. George Triadafilopoulos, Stanford</P>
Rubrieken
- advisering
- algemeen management
- coaching en trainen
- communicatie en media
- economie
- financieel management
- inkoop en logistiek
- internet en social media
- it-management / ict
- juridisch
- leiderschap
- marketing
- mens en maatschappij
- non-profit
- ondernemen
- organisatiekunde
- personal finance
- personeelsmanagement
- persoonlijke effectiviteit
- projectmanagement
- psychologie
- reclame en verkoop
- strategisch management
- verandermanagement
- werk en loopbaan